highlight
intrahost
divers
analyz
pbmc
andor
plasma
dengu
patient
viru
microevolut
shape
immun
pressur
replic
site
includ
pbmc
hotspot
aros
via
converg
microevolut
like
immuneescap
variant
hotspot
variant
evolutionarili
constrain
replic
defect
summari
dengu
caus
four
dengu
viru
serotyp
highli
preval
mosquitoborn
viral
diseas
human
yet
select
pressur
drive
denv
microevolut
within
human
host
intrahost
remain
unknown
employ
wholegenom
segment
amplif
approach
coupl
deep
sequenc
profil
intrahost
divers
peripher
blood
mononuclear
cell
pbmc
plasma
sampl
dengu
patient
intrahost
divers
appear
driven
immun
pressur
well
replic
success
pbmc
potenti
replic
site
hotspot
intrahost
variat
detect
patient
viral
envelop
premembranemembran
protein
togeth
form
virion
surfac
domin
variant
hotspot
aros
via
converg
microevolut
appear
immuneescap
variant
evolutionarili
constrain
macro
level
due
viral
replic
defect
dengu
thu
exampl
acut
infect
select
pressur
within
infect
individu
drive
rapid
intrahost
viru
microevolut
b
dengu
caus
highli
preval
viral
diseas
intrahost
divers
patient
show
intrahost
viru
microevolut
occur
pbmc
potenti
replic
site
find
intrahost
variant
like
immuneescap
hotspot
aris
via
converg
microevolut
yet
evolutionarili
constrain
replic
defect
dengu
viru
denv
mosquitoborn
flaviviru
singlestrand
rna
genom
caus
estim
million
infect
million
dengu
case
worldwid
everi
year
bhatt
et
al
four
close
relat
serotyp
denv
encod
three
structur
protein
capsid
c
premembranemembran
prmm
envelop
e
seven
nonstructur
ns
protein
infect
denv
result
spectrum
clinic
manifest
rang
asymptomat
infect
debilit
acut
febril
ill
dengu
fever
df
lifethreaten
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
major
determin
dengu
pathogenesi
includ
virul
infect
denv
strain
host
genet
factor
preexist
host
immun
respons
prior
infect
differ
denv
serotyp
halstead
yamarat
messer
et
al
nguyen
et
al
ohainl
et
al
ricohess
et
al
sequenti
infect
diseas
sever
appear
determin
complex
interplay
protect
enhanc
compon
preexist
immun
viral
antigen
halstead
peiri
porterfield
rothman
enni
intricaci
human
immun
respons
denv
infect
made
difficult
identifi
precis
mechan
trigger
progress
sever
diseas
also
engin
vaccin
therapeut
combat
diseas
replic
denv
within
host
produc
popul
genet
relat
distinct
genom
refer
intrahost
divers
due
errorpron
natur
viral
replicas
rnadepend
rna
polymeras
rdrp
domingo
holland
intrahost
variant
thought
serv
templat
evolutionari
mechan
act
shape
variat
consensu
level
host
ie
interhost
divers
lead
emerg
genet
distinct
strain
genotyp
denv
genet
variat
intrahost
popul
propos
influenc
diseas
outcom
pathogenesi
chronic
human
infect
rna
virus
hiv
hepat
c
viru
hcv
farci
et
al
joo
et
al
lee
et
al
moreau
et
al
sullivan
et
al
provid
consider
time
frame
month
year
discern
viru
evolut
respons
intrahost
select
pressur
similar
observ
also
report
chronic
infect
influenza
viru
noroviru
virus
usual
associ
acut
infect
bull
et
al
debbink
et
al
roger
et
al
valkenburg
et
al
studi
character
emerg
individu
variant
associ
immun
evas
drug
resist
unlik
chronic
infect
hand
studi
report
evolutionari
mechan
viral
genet
drive
viru
evolut
acut
human
infect
ebola
park
et
al
dengu
parameswaran
et
al
rodriguezroch
et
al
session
et
al
sim
et
al
thai
et
al
viru
evolut
sever
constrain
time
day
week
consequ
limit
inform
exist
fit
pathogenesi
profil
individu
intrahost
denv
variant
emerg
acut
human
infect
inform
intrahost
viral
divers
provid
new
perspect
assess
infect
outcom
diseas
pathogenesi
vaccin
therapeut
efficaci
individu
dengu
close
relat
viral
infect
zika
studi
employ
wholegenom
segment
amplif
approach
coupl
highthroughput
sequenc
profil
intrahost
viral
divers
across
entir
code
region
genom
consider
depth
coverag
use
snapshot
intrahost
divers
plasma
peripher
blood
mononuclear
cell
pbmc
sampl
individu
includ
pair
plasma
pbmc
sampl
enrol
prospect
pediatr
hospitalbas
studi
nicaragua
demonstr
diversif
human
acut
dengu
microevolut
shape
converg
select
pressur
includ
preexist
immun
possibl
replic
site
pbmc
constrain
sever
defect
replic
abil
pbmc
plasma
sampl
use
studi
collect
first
day
present
individu
age
month
year
primari
sampl
secondari
sampl
acut
symptomat
infect
epidem
season
managua
nicaragua
tabl
narvaez
et
al
major
pbmc
plasma
sampl
individu
present
df
rest
pbmc
plasma
sampl
individu
present
dhfdss
support
clinic
inform
provid
tabl
genom
amplifi
via
revers
transcript
pcr
use
sequencespecif
primer
pair
gener
overlap
amplicon
per
sampl
figur
multiplex
librari
highthroughput
sequenc
construct
pool
amplicon
mix
sequenc
illumina
hiseq
platform
yield
nt
pairedend
read
forward
read
revers
read
orient
refer
genom
reconstruct
sampl
use
langmead
salzberg
samtool
li
et
al
inhous
python
script
use
calcul
variat
nucleotid
codon
amino
acid
level
locu
code
region
see
star
method
filter
coverag
read
sanger
qualiti
score
median
coverag
per
codon
locu
read
read
dataset
respect
sampl
coverag
genom
retain
downstream
analys
pbmc
plasma
sampl
individu
includ
pair
pbmcplasma
dataset
individu
pass
threshold
genom
coverag
codingregion
coverag
sampl
vari
median
read
read
dataset
combin
tabl
percent
variant
divers
nucleotid
codon
amino
acid
loci
calcul
percent
read
span
coordin
differ
consensu
nucleotideand
codonlevel
divers
provid
aggreg
measur
nonsynonym
synonym
mutat
ie
mutat
chang
amino
acid
encod
respect
amino
acid
divers
captur
nonsynonym
mutat
studi
variant
abund
reproduc
across
replic
see
star
method
consid
variant
high
confid
unless
otherwis
specifi
use
highconfid
variant
investig
divers
pattern
sampl
sex
includ
intrahost
divers
comparison
signific
differ
sex
observ
calcul
intrahost
divers
metric
data
shown
evalu
snapshot
intrahost
divers
sampl
distinct
subset
individu
sampl
sampl
dengu
assess
effect
immunedriven
select
pressur
intrahost
denv
evolut
compar
percent
loci
per
protein
variant
sampl
dengu
found
significantli
fewer
uniqu
variant
loci
dengu
case
pbmc
figur
left
panel
p
plasma
figur
right
panel
p
sampl
observ
due
systemat
dispar
yield
viral
rna
sinc
measur
genom
equival
ge
per
millilit
extract
viral
rna
significantli
differ
case
pbmc
plasma
sampl
figur
left
right
panel
thu
appear
evolv
fewer
distinct
loci
genomewid
dengu
compar
dengu
suggest
viru
evolut
constrain
preexist
immun
pressur
dengu
addit
examin
locat
uniqu
variant
loci
expos
membraneassoci
surfac
e
protein
promin
target
antibodymedi
immun
human
dengu
detect
fewer
uniqu
variant
loci
across
sampl
dengu
case
compar
case
figur
top
bottom
panel
expos
membraneassoci
surfac
e
much
differ
contribut
pbmcspecif
variant
loci
thu
consist
genomewid
differ
dengu
breadth
viral
variant
repertoir
e
appear
reduc
dengu
compar
dengu
global
differ
viral
composit
naiv
individu
individu
preexist
immun
denv
indic
extent
divers
intrahost
popul
direct
immun
repertoir
acut
dengu
human
studi
investig
particular
epitop
help
resolv
specif
preexist
immun
pressur
contribut
differenti
rate
viral
microevolut
dengu
use
pattern
intrahost
divers
pair
pbmc
plasma
sampl
subset
individu
assess
role
select
pressur
mediat
human
immun
pathway
virion
intracellular
replic
success
shape
differ
denv
variant
pbmcplasma
ie
intracellularextracellular
interfac
explor
rel
contribut
pbmc
potenti
viral
replic
site
circul
virion
popul
plasma
examin
percent
abund
nonsynonym
variant
pbmc
plasma
bin
loci
whether
variant
found
level
pbmc
pbmc
pbmc
plasma
sampl
median
percent
abund
variant
genom
found
pbmc
significantli
lower
median
percent
abund
variant
genom
found
pbmc
plasma
nonsynonym
synonym
variant
figur
left
right
panel
p
thu
variant
appear
pbmc
plasma
abund
variant
restrict
pbmc
suggest
denv
variant
found
plasma
select
base
intracellular
replic
success
pbmc
also
found
evid
immunedriven
select
pressur
shape
differ
plasma
pbmc
denv
popul
particular
significantli
higher
abund
nonsynonym
variant
observ
plasma
compar
pbmc
prmm
protein
figur
p
major
target
human
b
cell
cell
immun
respons
respect
de
alwi
et
al
dejnirattisai
et
al
rivino
et
al
simmon
et
al
weiskopf
et
al
furthermor
observ
mani
dissimilar
pbmc
plasma
denv
popul
could
attribut
replic
defect
immun
pressur
mechan
instanc
minim
intersect
detect
locat
variant
loci
highli
antigen
e
protein
figur
green
loci
well
protein
figur
infer
presenc
fewer
green
line
repres
loci
amino
acid
variant
pbmc
plasma
sampl
compar
orang
red
line
repres
loci
amino
acid
variant
pbmc
plasma
sampl
respect
find
due
differ
depth
sequenc
coverag
data
shown
number
viral
copi
use
input
gener
sequenc
librari
figur
paramet
compar
pair
pbmc
plasma
sampl
observ
largescal
differ
plasma
pbmc
denv
variant
popul
taken
togeth
prior
knowledg
human
autopsi
studi
exist
signific
nonpbmc
compart
viral
replic
phagocyt
lymph
node
spleen
alveolar
macrophag
lung
perivascular
cell
brain
aye
et
al
balsiti
et
al
jessi
et
al
suggest
contribut
plasma
denv
popul
replic
compart
pbmc
next
sought
identifi
hotspot
intrahost
viral
divers
defin
loci
detect
intrahost
divers
multipl
host
pbmc
plasma
sampl
individu
infect
hotspot
may
aris
de
novo
within
host
due
converg
select
pressur
may
attribut
cotransmiss
wildtyp
wt
variant
virus
within
host
popul
probabl
detect
divers
hotspot
due
select
pressur
assum
low
acut
human
dengu
descloux
et
al
lin
et
al
parameswaran
et
al
thai
et
al
wang
et
al
wang
et
al
primarili
time
constraint
day
viru
evolut
within
host
analyz
percent
variant
abund
togeth
percent
preval
variant
codon
locu
depict
color
size
data
point
across
entir
code
region
found
codon
loci
hotspot
intrahost
divers
pbmc
plasma
sampl
figur
top
bottom
panel
respect
howev
promin
hotspot
divers
identifi
major
sampl
three
codon
coordin
correspond
amino
acid
membran
portion
prmm
hereaft
prm
prm
correspond
amino
acid
highli
conserv
abloop
region
e
domain
iii
e
figur
confirm
presenc
abund
e
variant
design
primer
specif
target
amplifi
either
wt
e
denv
rna
valid
specif
primer
use
rna
wt
e
variant
virus
figur
test
subset
seven
serum
sampl
use
studi
abl
directli
detect
e
hotspot
variant
variou
level
seven
clinic
sampl
figur
domin
variant
hotspot
ident
across
sampl
figur
exhibit
alter
amino
acid
sequenc
compar
consensu
glycin
serin
prmm
exhibit
signific
differ
amino
acid
aa
variant
pbmc
plasma
protein
includ
e
shown
exampl
exhibit
signific
differ
aa
variant
pbmc
plasma
p
ns
nonsignific
wilcoxon
signedrank
test
f
comparison
genom
equival
per
millilit
geml
extract
rna
pair
pbmc
plasma
sampl
ns
nonsignific
wilcoxon
signedrank
test
pair
sampl
prm
methionin
leucin
prm
histidin
leucin
e
figur
prm
prm
variant
significantli
preval
plasma
respect
compar
pbmc
sampl
respect
p
fisher
exact
test
e
variant
highli
preval
pbmc
plasma
sampl
figur
averag
read
read
valu
hotspot
detect
pcr
artifact
amplicon
librari
prepar
data
shown
even
lower
threshold
variant
abund
prm
prm
variant
detect
small
number
pbmc
sampl
sampl
figur
e
variant
thu
appear
origin
pbmc
addit
cell
type
wherea
conceiv
prm
aris
viral
replic
site
distinct
pbmc
although
rule
possibl
variant
aros
pbmc
simpli
enrich
extracellular
environ
prm
e
variant
constitut
respect
estim
geml
circul
viral
popul
plasma
extrapol
figur
median
yield
ge
ml
rna
extract
ml
plasma
individu
detect
level
variant
figur
median
abund
also
analyz
interhost
divers
fulllength
consensu
genom
genbank
found
even
though
exhibit
codonlevel
divers
prm
e
figur
left
panel
red
bar
viru
popul
invari
interhost
amino
acid
sequenc
three
hotspot
figur
right
panel
red
bar
tabl
suggest
macroevolutionari
ie
consensuslevel
constraint
loci
addit
major
hotspot
detect
sever
minor
hotspot
defin
loci
higher
variant
abund
sampl
pbmc
plasma
sampl
figur
minor
hotspot
mark
minor
hotspot
one
codon
polyprotein
appear
share
pbmc
plasma
sampl
divers
threshold
figur
minor
hotspot
loci
mark
exhibit
interhost
divers
codon
level
figur
left
panel
red
line
tabl
interhost
amino
acid
divers
observ
five
nine
minor
hotspot
figur
right
panel
red
line
tabl
overal
find
demonstr
hotspot
intrahost
viral
divers
detect
acut
human
dengu
furthermor
presenc
hotspot
variant
macroevolutionarili
conserv
loci
highlight
import
hostspecif
select
pressur
intrahost
evolut
next
explor
linkag
pattern
polymorph
sequenc
reconstruct
haplotyp
span
prm
e
major
hotspot
loci
identifi
whether
variant
prm
prm
hotspot
loci
present
viral
genom
virus
variat
prm
e
hotspot
aros
de
novo
differ
sampl
due
converg
select
pressur
present
multipl
host
due
cotransmiss
consensu
viral
genom
sampl
detect
level
prm
variant
popul
level
observ
haplotyp
prm
variant
also
includ
prm
variant
vice
versa
demonstr
prm
variant
link
ie
present
variant
viral
genom
figur
red
arrowhead
moreov
identifi
haplotyp
variant
one
prm
hotspot
figur
impli
evolv
independ
prm
prm
hotspot
prm
variant
thu
appear
result
sequenti
evolut
prm
prm
viral
genom
haplotyp
analysi
also
reveal
signific
interhost
divers
three
loci
proxim
prm
e
hotspot
figur
black
arrowhead
four
differ
haplotyp
wide
rang
frequenc
detect
among
consensu
genom
sampl
uniqu
combin
nucleotid
divers
loci
figur
tabl
nucleotid
three
polymorph
loci
concord
domin
wt
consensu
genom
prmm
e
variant
genom
sampl
figur
tabl
variant
genom
mark
true
even
sampl
lowfrequ
consensu
haplotyp
cat
agg
haplotyp
prmm
e
respect
sampl
mix
infect
multipl
wt
haplotyp
detect
figur
genom
mark
genet
concord
wt
variant
haplotyp
sampl
strongli
support
independ
emerg
andor
expans
hotspot
variant
within
individu
although
complet
exclud
contribut
cocircul
variant
prm
e
loci
taken
togeth
observ
indic
variant
prm
e
hotspot
loci
aros
converg
evolut
acut
dengu
least
four
independ
event
correspond
presenc
variant
four
distinct
haplotyp
fourplasmid
revers
genet
approach
use
engin
chimer
infecti
clone
contain
nonstructur
gene
sri
lankan
isol
genbank
either
nicaraguan
consensu
sequenc
structur
gene
wt
wt
nicaraguan
consensu
mutat
membran
portion
prmm
prm
mutant
wt
nicaraguan
consensu
mutat
ab
loop
e
e
mutant
evalu
replic
phenotyp
wt
mutant
virus
mosquito
cell
directli
compet
mutant
viru
wt
viru
coinfect
experi
quiner
et
al
viral
rna
mixtur
input
cellular
supernat
collect
day
post
infect
dpi
sequenc
sanger
method
captur
ratio
wt
mutant
nucleotid
prm
e
hotspot
use
polysnp
program
replic
index
calcul
log
valu
rel
level
wt
mutant
virus
supernat
compar
rel
level
input
neg
prm
e
mutant
virus
dpi
indic
mutant
replic
defect
cell
compar
wt
figur
addit
assess
replic
phenotyp
wt
mutant
virus
human
monocyt
cell
line
express
dcsign
coreceptor
denv
entri
tassaneetrithep
et
al
singl
infect
perform
cell
gecel
wt
prm
e
virus
three
virus
abl
establish
infect
cell
howev
percent
infect
cell
consider
reduc
infect
prm
e
variant
compar
wt
viru
dpi
determin
anti
antibodi
figur
left
right
panel
respect
revert
detect
dpi
either
variant
data
shown
e
variant
also
exhibit
temperaturesensit
c
versu
c
plaqu
phenotyp
babi
hamster
kidney
cell
better
plaqu
c
wherea
prm
variant
plaqu
rel
well
c
figur
result
thu
demonstr
prm
e
mutant
virus
establish
infect
mosquito
cell
human
cell
mammalian
cell
consider
reduc
effici
due
deleteri
effect
mutat
viral
replic
abil
prm
e
mutant
virus
exhibit
defect
entri
behav
similar
wt
viru
demonstr
directli
compar
entri
capabl
three
virus
use
cell
c
figur
suggest
replic
defect
prm
e
mutant
virus
downstream
viru
entri
anticip
mutat
direct
impact
viral
rna
replic
none
denv
structur
protein
except
rna
element
capsid
gene
byk
gamarnik
clyde
et
al
de
borba
et
al
frieb
et
al
selisko
et
al
implic
direct
role
rna
replic
studi
zheng
et
al
mutat
prm
shown
result
impair
prm
process
decreas
viral
infect
prm
prm
situat
amino
acid
away
prm
given
absenc
entri
replic
defect
hypothes
prm
hotspot
mutat
like
impair
prm
process
denv
infect
mechan
similar
prm
zheng
et
al
even
though
prm
antibodi
identifi
sever
group
beltramello
et
al
dejnirattisai
et
al
immun
pressur
drive
evolut
prmm
locu
poorli
understood
origin
prm
variant
virus
remain
elus
contrast
significantli
known
function
antigen
loci
e
protein
specif
e
locu
previou
studi
shown
e
play
phsens
role
mediat
viral
fusion
endosom
postentri
stage
nelson
et
al
suggest
virus
e
hotspot
mutat
like
impair
stage
viral
membran
fusion
endosom
membran
interestingli
process
viral
membran
fusion
appear
signific
target
antidenv
antibodi
infect
human
fusion
loop
antibodi
make
signific
proport
popul
broadli
reactiv
antibodi
elicit
infect
denv
goncalvez
et
al
lai
et
al
given
converg
natur
immun
respons
preval
e
variant
conceiv
e
variant
aros
immuneescap
variant
fusion
loop
antibodi
inde
goncalvez
et
al
demonstr
cycl
passag
presenc
antifus
loop
mab
escap
mutat
isol
e
support
claim
immun
pressur
exert
fusion
loop
antibodi
play
key
role
converg
select
variant
analog
e
hotspot
locu
taken
togeth
conclud
e
hotspot
variant
despit
possibl
possess
immuneescap
advantag
constrain
intrahost
evolutionari
system
sever
defect
associ
viral
membran
fusion
post
entri
thu
demonstr
intrahost
popul
rapidli
converg
evolv
acut
human
infect
viru
microevolut
possibl
shape
viral
replic
compart
distinct
pbmc
driven
part
immun
select
pressur
constrain
replic
defect
macroevolutionari
scale
particular
identifi
highli
preval
denv
variant
e
like
aros
immuneescap
variant
respons
pressur
exert
fusion
loop
antibodi
yet
constrain
sever
replic
defect
like
incur
due
defici
viral
membran
fusion
host
endosom
post
entri
identif
converg
immun
pressur
appear
result
select
preval
immuneescap
variant
especi
one
constrain
replic
defect
fit
cost
could
har
intellig
select
new
candid
target
vaccinedrug
design
snapshot
intrahost
denv
divers
help
identifi
mechan
drive
viru
microevolut
human
dengu
provid
new
perspect
assess
infect
outcom
diseas
pathogenesi
vaccin
therapeut
efficaci
individu
detail
method
provid
onlin
version
paper
includ
follow
debbink
k
lindesmith
lc
ferri
mt
swanstrom
j
beltramello
corti
lanzavecchia
baric
rs
withinhost
evolut
result
antigen
distinct
norovirus
j
virol
dejnirattisai
w
jumnainsong
onsirisakul
n
fitton
p
vasanawathana
limpitikul
w
puttikhunt
c
edward
c
duangchinda
supasa
et
al
crossreact
antibodi
enhanc
dengu
viru
infect
human
scienc
descloux
e
caolormeau
vm
roch
c
de
lamballeri
x
domingo
e
holland
jj
rna
viru
mutat
fit
surviv
annu
rev
microbiol
farci
p
strazzera
r
alter
hj
farci
degioanni
coiana
peddi
g
usai
f
serra
g
chessa
l
et
al
earli
chang
hepat
c
viral
quasispeci
interferon
therapi
predict
therapeut
outcom
proc
natl
acad
sci
usa
frieb
p
shi
py
harri
e
downstream
aug
region
element
requir
mosquitoborn
flaviviru
rna
replic
j
virol
virol
gire
sk
goba
andersen
kg
sealfon
rs
park
dj
kanneh
l
jalloh
momoh
fullah
duda
g
et
al
genom
surveil
elucid
ebola
viru
origin
transmiss
outbreak
scienc
goncalvez
ap
purcel
rh
lai
cj
epitop
determin
chimpanze
fab
antibodi
effici
crossneutr
dengu
type
type
virus
map
insid
close
proxim
fusion
loop
dengu
type
viru
envelop
protein
zagordi
bhattacharya
eriksson
n
beerenwinkel
n
shorah
estim
genet
divers
mix
sampl
nextgener
sequenc
data
bmc
bioinformat
zheng
yuan
f
kleinfelt
lm
kielian
toggl
switch
control
low
phtrigger
rearrang
matur
dengu
viru
envelop
protein
nat
commun
inform
request
resourc
reagent
direct
fulfil
lead
contact
dr
eva
harri
eharri
berkeleyedu
studi
approv
institut
review
board
irb
univers
california
berkeley
nicaraguan
ministri
health
written
consent
obtain
parentsleg
guardian
pediatr
subject
assent
also
obtain
subject
six
year
age
older
pbmc
plasma
sampl
obtain
subject
ongo
prospect
hospitalbas
studi
pediatr
dengu
nicaragua
establish
hammond
et
al
enrol
patient
present
suspect
dengu
nation
pediatr
refer
hospit
managua
nicaragua
plasma
pbmc
collect
patient
three
sequenti
day
acut
phase
ill
convalesc
day
longitudin
month
criteria
identifi
dengueposit
case
classifi
immun
statu
describ
gutierrez
et
al
narvaez
et
al
dengu
case
classifi
df
dhf
dss
accord
dengu
guidelin
narvaez
et
al
thirtyon
plasma
peripher
blood
mononuclear
cell
pbmc
sampl
individu
includ
pair
plasma
pbmc
sampl
analyz
studi
gender
ident
well
age
patient
list
tabl
extens
epidemiolog
clinic
data
avail
sampl
sampl
size
studi
determin
avail
pediatr
patient
sampl
primari
secondari
dengu
case
caus
within
singl
endem
year
subgroup
within
patient
studi
select
base
sampl
type
plasma
versu
pbmc
clinic
classif
exampl
primari
versu
secondari
dengu
dengu
fever
versu
dengu
hemorrhag
fever
dengu
shock
syndrom
gene
origin
variat
base
gene
annot
babi
hamster
kidney
cell
clone
maintain
amem
gibco
supplement
heatinactiv
fetal
bovin
serum
fb
gibco
mm
hepe
gibco
uml
penicillin
mgml
streptomycin
penstrep
gibco
c
co
cell
gift
dr
ralph
baric
maintain
mem
hepe
supplement
heatinactiv
fb
nonessenti
amino
acid
neaa
gibco
mm
lglutamin
gibco
penstrep
c
co
cell
express
dcsign
gift
dr
aravinda
de
silva
maintain
rpmi
medium
gibco
supplement
fb
pen
strep
hepe
c
co
hybrid
trizolrneasi
protocol
develop
viral
rna
recoveri
pbmc
briefli
pbmc
lyse
trizol
life
technolog
aqueou
phase
rna
extract
addit
chloroform
next
volum
buffer
rlt
rneasi
mini
kit
qiagen
volum
ethanol
ad
rna
solut
mixtur
appli
rneasi
column
wash
rna
elut
perform
describ
rneasi
kit
protocol
viral
rna
plasma
sampl
extract
use
qiaamp
viral
rna
mini
kit
qiagen
describ
manufactur
protocol
rna
elut
ml
rnasefre
water
contain
linear
polyacrylamid
ml
life
technolog
carrier
rna
ml
qiagen
superasein
ml
life
technolog
twelv
rtpcr
amplif
set
sampl
variou
combin
forward
revers
primer
tabl
reagent
superscript
iii
onestep
rtpcr
system
invitrogen
reaction
use
ul
cultur
medium
c
wash
twice
pb
c
lysi
buffer
ad
cell
pellet
rna
extract
perform
use
rneasi
mini
kit
qiagen
qrtpcr
perform
describ
differ
statist
analys
perform
specifi
correspond
result
main
text
figur
legend
describ
analysi
fisher
exact
test
figur
main
text
wilcoxon
test
unpair
sampl
figur
figur
legend
wilcoxon
signedrank
test
figur
figur
legend
wilcoxon
signedrank
test
pair
sampl
figur
figur
legend
signific
gener
defin
p
p
p
also
indic
applic
number
sampl
n
use
comparison
indic
figur
legend
well
main
text
briefli
sampl
individu
individu
dengu
use
comparison
present
figur
sampl
pair
pbmc
plasma
sampl
use
figur
sampl
pair
pbmc
plasma
sampl
use
figur
sampl
pbmc
plasma
sampl
use
figur
figur
fulllength
genom
analyz
data
pbmcplasma
sampl
prmm
hotspot
pbmcplasma
sampl
e
hotspot
shown
figur
data
independ
experi
use
figur
fastq
file
sequenc
gener
studi
deposit
ncbi
sequenc
read
archiv
access
use
bioproject
id
